Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors

导出原文传递

翻译打印收藏纠错

作者： Andersen,J.B. ^[1] ; Spee,B. ^[2] ; Blechacz,B.R. ^[3] ; Avital,I. ^[4] ; Komuta,M. ^[5] ; Barbour,A. ; Conner,E.A. ; Gillen,M.C. ; Roskams,T. ; Roberts,L.R. ; Factor,V.M. ; Thorgeirsson,S.S.

作者单位： Surgery Branch, National Institutes of Health, Bethesda, MD, United States ^[1] Mayo Clinic, Rochester, MN, United States ^[2] Laboratory of Experimental Carcinogenesis, National Institutes of Health, Bethesda, MD, United ^[3] University of Queensland, Brisbane, Australia ^[4] University of Leuven, Leuven, Belgium ^[5]

关键词 CCA Gene Expression Genetic Analysis Hepatic

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

Gastroenterology

2012年142卷4期

1021-1031页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors

Gastroenterology

相似文献

Gastroenterology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors

Gastroenterology

相似文献

Gastroenterology

相关期刊

检索历史清除